Drug comparisons
Fremanezumab vs Almotriptan
Compare Fremanezumab vs Almotriptan: CGRP antibody for prevention vs 5-HT agonist for acute migraines. See efficacy, safety, and when each is preferred.
No comparison dimensions are available for this page.
Clinical context
Patients with frequent migraines evaluating a switch from acute triptan use to CGRP preventive therapy or combination treatment.
Bottom line
Fremanezumab suits migraine prevention while Almotriptan targets acute attacks, so neither is inherently superior.
All medication comparisons